{"componentChunkName":"component---src-templates-blog-post-js","path":"/pharmacovigilance/index2/","result":{"data":{"site":{"siteMetadata":{"title":"Medwork","author":"Ioannis Tsiakkas"}},"markdownRemark":{"id":"0077f5e0-7f86-5c9e-a712-e32a8b6fed5a","excerpt":"","html":"<div>\n    <script src=\"src/pages/services.js\"></script>\n    <p>\n        Compliance with pharmacovigilance requirements is becoming an increasing challenge for pharmaceutical companies worldwide. In this very demanding environment,\n        Medwork offers a reliable solution for every need related to drug safety.\n        We have an extensive Pharmacovigilance Department composed of a team of 21 pharmacovigilance professionals and four medical advisors.\n        Our clients range from small local companies to large international corporations. Currently [Dec 2021 data], we have over 117\n        active contracts with more than 77 clients relating to pharmacovigilance activities.\n        Our services may be fully customized to cover all of a Marketing Authorization Holderâ€™s responsibilities related to drug safety.\n    </p>\n    Medwork's dedicated professionals will ensure full compliance of Marketing Authorization Holders with their regulatory obligations. We provide full pharmacovigilance coverage as well as tailored services that cover specific needs. Our services include:\n    <br />\n    <br />\n    <b>Full Post-Marketing Pharmacovigilance Support:</b>\n    <br />\n    <ul>\n    <li>Establishment of a pharmacovigilance System</li>\n    <li>Undertaking EU QPPV/deputy EU QPPV responsibility</li>\n    <li>Local & global literature review</li>\n    <li>Compilation and maintenance of the PSMF</li>\n    <li>Safety information processing</li>\n    <li>Writing and/or reviewing periodic reports</li>\n    <li>Writing RMPs</li>\n    <li>Interaction with Eudravigilance database including XEVMPD</li>\n    <li>DHPC management</li>\n    <li>Pharmacovigilance personnel back-up</li>\n    <li>Training of pharmacovigilance and non-pharmacovigilance personnel</li>\n    <li>Consulting</li>\n    </ul>\n    <b>Clinical Trials Pharmacovigilance Support:</b>\n    <ul>\n    <li>Provision of Responsible Person for pharmacovigilance (RP) for clinical trials</li>\n    <li>Eudravigilance registration</li>\n    <li>Assessment and medical review of serious adverse events</li>\n    <li>SUSAR reporting to Eudravigilance and Competent Authorities</li>\n    <li>Ongoing risk/benefit assessment of the IMP</li>\n    <li>Compilation and update of the DSUR</li>\n    </ul>\n</div>","frontmatter":{"title":"Pharmacovigilance","date":"February 01, 2022","description":null,"thumbnail":{"childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":5.964912280701754,"src":"/static/17fe344ef18fb678602b37f4c5e0fe65/a6352/pharmacovigilance.jpg","srcSet":"/static/17fe344ef18fb678602b37f4c5e0fe65/722c4/pharmacovigilance.jpg 340w,\n/static/17fe344ef18fb678602b37f4c5e0fe65/1d671/pharmacovigilance.jpg 680w,\n/static/17fe344ef18fb678602b37f4c5e0fe65/a6352/pharmacovigilance.jpg 960w","sizes":"(max-width: 960px) 100vw, 960px"}}}}}},"pageContext":{"slug":"/pharmacovigilance/index2/","previous":{"fields":{"slug":"/qualityManagment/"},"frontmatter":{"title":"Quality Managment"}},"next":null}},"staticQueryHashes":["63159454"]}